Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Tsitologiia ; 47(5): 404-16, 2005.
Artigo em Russo | MEDLINE | ID: mdl-16706144

RESUMO

Mesenchymal stem cells (MSCs) have an ability to migrate in the organism to injured tissue to exert influence on inflammation and reparation in these regions. The aim of this study was to determine the optimal time of MSCs transplantation for myocardial reparation in rat experimental heart failure. The experiments were carried out on inbred line Wistar-Kyoto rats. Myocardial experimental infarction (EI) was induced by ligation of the left descending coronary artery. MSCs were isolated from bone marrow, cultivated in vitro and injected into the tail vein on the day of experimental infarction operation. It was shown that the time of MSCs transplantation exerted an essential influence on angiogenesis in a damaged myocardium, on ventricular dilatation and morphological structure of the scar. The best time for MSCs transplantation was determined within two days before EI, and seven days after EI. As a result, the overload of the border zone of infarct region decreased, and no features of infarction relapse were shown in the border zone.


Assuntos
Coração/fisiologia , Transplante de Células-Tronco Mesenquimais , Infarto do Miocárdio/cirurgia , Regeneração , Animais , Modelos Animais de Doenças , Masculino , Ratos , Ratos Endogâmicos WKY , Fatores de Tempo
2.
Tsitologiia ; 46(12): 1043-54, 2004.
Artigo em Russo | MEDLINE | ID: mdl-15747834

RESUMO

Mesenchymal stem cells (MSC) are resident pluripotent cells of bone marrow stroma. MSC have the ability to differentiate into osteoblasts, chondroblasts and adipocytes, neurons, glia and also into cardiomyocytes. The problem of MSC use in cell therapy of various diseases and in myocardial infarction therapy is widely discussed at present. The experiments were carried out on the inbred line Wistar--Kyoto rats. Myocardial experimental infarction (EI) was induced by left descending coronary artery ligation. MSC were isolated from bone marrow, cultivated in vitro and injected into the tail vein on the day of experimental infarction operation. It was shown that the structure of injured myocardium in experimental group significantly differed from that in control group. MSC transplantation led to inflammatory process acceleration and to increased angiogenesis in the damaged myocardium; also, live cardiomyocyte layers were detected in the scar. As a result, ventricular dilatation and overload of the border zone of infarct region decreased, no features of infarction relapse were shown in the border zone.


Assuntos
Transplante de Células-Tronco Mesenquimais , Infarto do Miocárdio/terapia , Miocárdio/patologia , Animais , Modelos Animais de Doenças , Masculino , Infarto do Miocárdio/fisiopatologia , Miócitos Cardíacos/fisiologia , Neovascularização Fisiológica , Ratos , Ratos Endogâmicos WKY , Remodelação Ventricular
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA